Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study

BACKGROUND: Several anti-cytokine therapies were tested in the randomized trials in hospitalized patients with severe acute respiratory syndrome coronavirus 2 infection (COVID-19). Previously, dexamethasone demonstrated a reduction of case-fatality rate in hospitalized patients with respiratory fail...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanevich, O. V., Fomina, D. S., Bakulin, I. G., Galeev, S. I., Bakin, E. A., Belash, V. A., Kulikov, A. N., Lebedeva, A. A., Lioznov, D. A., Polushin, Yu. S., Shlyk, I. V., Vorobyev, E. A., Vorobyeva, S. V., Surovceva, T. V., Bakulina, N. V., Lysenko, M. A., Moiseev, I. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693127/
https://www.ncbi.nlm.nih.gov/pubmed/34937556
http://dx.doi.org/10.1186/s12879-021-06982-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693127/
https://www.ncbi.nlm.nih.gov/pubmed/34937556
http://dx.doi.org/10.1186/s12879-021-06982-z

Ejemplares similares